These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15012111)
1. Rational design of a supra C-1027: kinetically stabilized analogue of the antitumor enediyne chromoprotein. Usuki T; Inoue M; Hirama M; Tanaka T J Am Chem Soc; 2004 Mar; 126(10):3022-3. PubMed ID: 15012111 [TBL] [Abstract][Full Text] [Related]
2. Antitumor enediyne chromoprotein C-1027: mechanistic investigation of the chromophore-mediated self-decomposition pathway. Inoue M; Usuki T; Lee N; Hirama M; Tanaka T; Hosoi F; Ohie S; Otani T J Am Chem Soc; 2006 Jun; 128(24):7896-903. PubMed ID: 16771503 [TBL] [Abstract][Full Text] [Related]
3. Specific interaction between a novel enediyne chromophore and apoprotein in macromolecular antitumor antibiotic C-1027. Matsumoto T; Okuno Y; Sugiura Y Biochem Biophys Res Commun; 1993 Sep; 195(2):659-66. PubMed ID: 8373405 [TBL] [Abstract][Full Text] [Related]
4. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore. Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295 [TBL] [Abstract][Full Text] [Related]
5. Disruption of cagA, the apoprotein gene of chromoprotein antibiotic C-1027, eliminates holo-antibiotic production, but not the cytotoxic chromophore. Cui Z; Wang L; Wang S; Li G; Hong B FEMS Microbiol Lett; 2009 Nov; 301(1):57-68. PubMed ID: 19845765 [TBL] [Abstract][Full Text] [Related]
6. ESR studies on DNA cleavage induced by enediyne C-1027 chromophore. Usuki T; Inoue M; Akiyama K; Hirama M Bioorg Med Chem; 2005 Sep; 13(17):5218-24. PubMed ID: 15979878 [TBL] [Abstract][Full Text] [Related]
7. Total synthesis of the C-1027 chromophore core: extremely facile enediyne formation through Sml2-mediated 1,2-elimination. Inoue M; Ohashi I; Kawaguchi T; Hirama M Angew Chem Int Ed Engl; 2008; 47(9):1777-9. PubMed ID: 18213563 [No Abstract] [Full Text] [Related]
8. Optimization of the assembly efficiency for lidamycin chromophore bound to its apoprotein: a case study using orthogonal array. Zhong GS; Guo XF; Zhang SH; Zhen YS Biomed Environ Sci; 2011 Dec; 24(6):602-7. PubMed ID: 22365395 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between the molecular composition of C1027, a new macromolecular antibiotic with enediyne chromophore, and its antitumor activity]. Shao RG; Zhen YS Yao Xue Xue Bao; 1995; 30(5):336-42. PubMed ID: 7660803 [TBL] [Abstract][Full Text] [Related]
10. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli. Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081 [TBL] [Abstract][Full Text] [Related]
11. Computer modeling analysis for enediyne chromophore-apoprotein complex of macromolecular antitumor antibiotic C-1027. Okuno Y; Otsuka M; Sugiura Y J Med Chem; 1994 Jul; 37(15):2266-73. PubMed ID: 8057275 [TBL] [Abstract][Full Text] [Related]
12. Binding capability of the enediyne-associated apoprotein to human tumors and constitution of a ligand oligopeptide-integrated protein. Cai L; Chen H; Miao Q; Wu S; Shang Y; Zhen Y J Biotechnol; 2009 Oct; 144(2):142-50. PubMed ID: 19737585 [TBL] [Abstract][Full Text] [Related]
13. Cloning and nucleotide sequencing of the antitumor antibiotic C-1027 apoprotein gene. Sakata N; Ikeno S; Hori M; Hamada M; Otani T Biosci Biotechnol Biochem; 1992 Oct; 56(10):1592-5. PubMed ID: 1369059 [TBL] [Abstract][Full Text] [Related]
14. The proteolytic specificity of the natural enediyne-containing chromoproteins is unique to each chromoprotein. Zein N; Reiss P; Bernatowicz M; Bolgar M Chem Biol; 1995 Jul; 2(7):451-5. PubMed ID: 9383447 [TBL] [Abstract][Full Text] [Related]
15. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein. Hariharan P; Sudhahar CG; Chou SH; Chin DH Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297 [TBL] [Abstract][Full Text] [Related]
16. [Antitumor activity of new antitumor antibiotic C1027 and its monoclonal antibody assembled conjugate]. Shao RG; Zhen YS Yao Xue Xue Bao; 1992; 27(7):486-91. PubMed ID: 1442079 [TBL] [Abstract][Full Text] [Related]
17. An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity. Zheng YB; Shang BY; Li Y; Zhen YS Biomed Pharmacother; 2013 Mar; 67(2):164-71. PubMed ID: 23206754 [TBL] [Abstract][Full Text] [Related]
18. [A monoclonal antibody directed against an enediyne antitumor antibiotic and its preliminary application]. Zhou CS; Xu LN; Jiang M; Zhen YS Yao Xue Xue Bao; 1997; 32(1):28-32. PubMed ID: 11243214 [TBL] [Abstract][Full Text] [Related]
19. Construction of a genetically engineered chimeric apoprotein consisting of sequences derived from lidamycin and neocarzinostatin. Jiang W; Shang B; Li L; Zhang S; Zhen Y Anticancer Drugs; 2016 Jan; 27(1):24-8. PubMed ID: 26457548 [TBL] [Abstract][Full Text] [Related]
20. Design of a new warhead for the natural enediyne dynemicin A. An increase of biological activity. Kraka E; Tuttle T; Cremer D J Phys Chem B; 2008 Mar; 112(9):2661-70. PubMed ID: 18269275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]